Company Filing History:
4 out of 314 
1 out of 1,235 Years Active: 2011-2014
Title: Kumi Abe: Innovator in Glycine Transporter-Inhibiting Substances
Introduction
Kumi Abe is a notable inventor based in Toshima-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target glycine transporters. With a total of 4 patents to his name, Abe's work is focused on addressing various mental health disorders and cognitive impairments.
Latest Patents
Abe's latest patents include innovative compounds that inhibit glycine transporters. These compounds are designed to prevent or treat a range of diseases, including schizophrenia, Alzheimer's disease, cognitive impairment, dementia, and various anxiety disorders. His inventions also target conditions such as depression, drug dependence, and Parkinson's disease, showcasing the potential of glycine uptake-inhibiting actions in therapeutic applications.
Career Highlights
Throughout his career, Kumi Abe has worked with prominent companies in the pharmaceutical industry. Notable among these are Taisho Pharmaceutical Co., Ltd. and Nissan Chemical Industries Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Abe has collaborated with several professionals in his field, including Xiang-Min Sun and Hiroshi Ohta. These partnerships have likely enhanced the scope and impact of his research and inventions.
Conclusion
Kumi Abe's contributions to the field of pharmaceuticals, particularly through his patents on glycine transporter-inhibiting substances, highlight his role as an innovator. His work addresses critical health issues and demonstrates the importance of continued research in mental health treatments.